Seminario 10 PARTE B Introducción a la Genética Medica - María Paz Bidondo — Transcript
Full transcript
- 0:03Hello, I hope you are well. I am María
- 0:06Pazvidondo and we are going to start
- 0:08watching part B of seminar 10.
- 0:15Previously, in seminar A, we saw what
- 0:18we call genotype; that is, those
- 0:20specific sequences that, in general,
- 0:23are genes and their alleles, and how,
- 0:26uh, those genes, when comparing the
- 0:29alleles of an individual with each
- 0:32other and with a reference sequence, we
- 0:35talked about whether there was
- 0:37homozygosity, heterozygosity, compound
- 0:42heterozygosity or hemisigosis. We also
- 0:45talked about different levels at which
- 0:48one could define a phenotype and be
- 0:51able to make associations between
- 0:53genotype and phenotype, that is,
- 0:56certain variants. And one
- 0:58characteristic: evaluating, for example
- 1:01, a clinical phenotype that is healthy
- 1:05individuals versus affected individuals
- 1:08within a family or within a population,
- 1:11or vice versa; Based on a clinical
- 1:13phenotype, such as a sign of an
- 1:16affectation, we can see what type of
- 1:19variants could be associated and
- 1:21whether these variants also had the
- 1:24potential to be pathogenic, that is, to
- 1:28cause the disease. We often have the
- 1:32genotype information through sequencing
- 1:34, and the phenotype information through
- 1:36different techniques according to the
- 1:38level of organization at which we are
- 1:41evaluating the phenotype. However, we
- 1:45are often left with questions about the
- 1:48mechanism that causes the product of
- 1:51the variant or products to interact
- 1:54with each other, at the level of other
- 1:57genetic and environmental contexts to
- 2:00generate the phenotype. In other words,
- 2:03what happens at the molecular level?
- 2:05What happens with the regulation of
- 2:06expression? What happens with the
- 2:09cellular behaviors during embryonic
- 2:10development that end up giving rise to
- 2:12this phenotype? In this second part or
- 2:19part B, we are going to focus on all
- 2:21this information, which is increasingly
- 2:23expanding with the incorporation of
- 2:25genomics into medicine. All of this
- 2:29that we are seeing about the
- 2:31correlations between genotype and
- 2:34phenotype forms part of a branch or
- 2:36medical specialty that can be applied
- 2:39to different elements of the health and
- 2:42disease process. What I mean by this is
- 2:46that medical geneticists and clinical
- 2:48geneticists are basically general
- 2:50practitioners who graduate from medical
- 2:53school and then do a three or four-year
- 2:55residency, depending on the institution
- 2:58in which they do it, and then graduate
- 3:00with a degree in this specialty, which
- 3:03is medical genetics. I can tell you
- 3:07that one of the places where you can do
- 3:09your medical genetics specialty is at
- 3:12the National Center for Medical
- 3:14Genetics, SENAGEM. The specialty lasts
- 3:18four years and is currently located at
- 3:20the Rivadavia Hospital in the
- 3:22Autonomous City of Buenos Aires. What
- 3:27is it that we clinical geneticists do,
- 3:30and how exactly do we apply our
- 3:32specialty to patients, to populations,
- 3:34and to our families? Well, many times
- 3:39we assess risks, that is, we look for
- 3:42variants to detect carriers of
- 3:44different types of entities that can be
- 3:47used to establish the risk of
- 3:50occurrence or recurrence through
- 3:52genetic counseling, so that people can
- 3:56make informed decisions regarding
- 3:58prevention. Other times we do prenatal
- 4:03screening tests, either in terms of
- 4:05genotype, the cardiac type of the
- 4:07product of gestation, or at a
- 4:08morphological level. Prenatal detection
- 4:12can be done, for example, through
- 4:14ultrasound, to see if any malformations
- 4:16have been detected or not. We also do
- 4:20some private neonatal screenings in
- 4:23newborns, mainly looking for possible
- 4:27metabolic diseases and then trying to
- 4:30prevent their consequences through
- 4:33timely treatment. We also directly
- 4:38diagnose diseases, both diseases that
- 4:41we classically call monogenic, where
- 4:44there is a main causative gene, and
- 4:46those that we call common, polygenic,
- 4:49or multifactorial disorders, which we
- 4:51will also discuss in upcoming seminars.
- 4:57Many times, the variants found in the
- 4:59genotype can be used to choose a
- 5:02specific treatment or as prognostic
- 5:04factors and monitoring of some adult
- 5:07diseases, such as neurodegenerative or
- 5:09oncological diseases. In addition,
- 5:14today, the branch of pharmacogenomics
- 5:17tries to identify, based on the gene
- 5:19variants of individuals, which
- 5:22therapies and medications will have
- 5:24fewer adverse effects and greater
- 5:26effectiveness for that person. Another
- 5:32treatment that is currently making
- 5:35great progress is those based on gene
- 5:37editing and gene therapies. Therefore,
- 5:43consultations, as you can see, in this
- 5:45branch or specialty can be
- 5:46preconception. A couple who are
- 5:50planning their pregnancy and want to
- 5:52know the risks before planning it, can
- 5:55be prenatal during gestation, as I
- 5:57mentioned earlier, they can be in the
- 5:59newborn, in the pediatric stage, in
- 6:01adolescence or in adulthood. What does
- 6:07a geneticist do in the consultation? We
- 6:13basically follow the same steps as
- 6:16other clinical doctors. First, we do
- 6:22what I already told you, that patients
- 6:24often come at different times in their
- 6:27life cycle. The first thing we do, this
- 6:32thing called anamnesis, is ask about
- 6:34their own and family history and with
- 6:37that we create a family tree. We
- 6:42perform complete physical exams, that
- 6:44is, we examine the patients and there
- 6:47we make an initial diagnostic
- 6:48integration. We ask ourselves, do this
- 6:51person and their family have risk
- 6:54factors? Do they have any specific
- 6:56signs? And from there we say, "Well, I
- 6:59have this main hypothesis of the health
- 7:01problem they are having and these
- 7:02secondary hypotheses." With this
- 7:07hypothetical set of main and secondary
- 7:10hypotheses, well, in order to confirm
- 7:13or reject these hypotheses, we decide
- 7:15to consult with other specialties such
- 7:18as an endocrinologist, a neurologist, a
- 7:21cardiologist. We can request a specific
- 7:25genetic test. We will see that there
- 7:29are different tests such as sequencing,
- 7:31such as specific highlighting PCs, such
- 7:34as whether we need CGH or CSF, etc. We
- 7:36may request additional studies to
- 7:38determine the condition of the internal
- 7:41organs that we do not observe during
- 7:43the external physical examination. For
- 7:47example, we might request X-rays, or
- 7:49perhaps we could order CT scans or
- 7:51brain MRIs. We conduct literature
- 7:54searches and search databases to
- 7:56determine which phenotypes similar to
- 7:58those of our patients have been
- 8:00previously identified or whether the
- 8:03variants exist. And with these results
- 8:07we think again and say, "Well, we were
- 8:09able to confirm a hypothesis with the
- 8:11highest degree of certainty, we were
- 8:13able to reject the others." If we did,
- 8:18we move on to a stage that is genetic
- 8:20counseling, that is, explaining what
- 8:22the specific diagnosis is, what the
- 8:25follow-up guidelines are, the risks of
- 8:27recurrence, how to improve the quality
- 8:29of life of this patient and this family
- 8:32. And if not, well, we go back to
- 8:38reviewing the physical exam, again more
- 8:40interconsultations, other genetic
- 8:42studies, proposing new hypotheses.
- 8:45Today, of this entire journey, we are
- 8:48going to focus mainly on the
- 8:51preparation of family trees. We are
- 8:54going to see a little bit about the
- 8:56physical exam, but since this is the
- 8:58first year of medical school, we are
- 9:00not going to focus on that right now.
- 9:03And genetic counseling, which is
- 9:05another important part of this journey,
- 9:08we will surely see it in one of the
- 9:10last seminars. Why do we ask? Why do we
- 9:17create family trees? To research risk
- 9:21factors that can help us prevent or
- 9:24serve to guide a diagnosis? What is the
- 9:28purpose of asking questions? To detect
- 9:32affected individuals as early as
- 9:34possible in order to give the
- 9:36individual, their family, or the
- 9:38population we are studying access to
- 9:40the right to health. In other words,
- 9:44access, for example, to genetic entity
- 9:47studies. Let's learn about some risk
- 9:51conditions or factors. For example, a
- 9:55risk condition could be advanced
- 9:58maternal age at birth, for example,
- 10:01over 35 years of age at birth. One
- 10:05might say, this person has an advanced
- 10:08maternal age that increases the
- 10:10probability of having pregnancies with
- 10:13autosomal trisomies. In other words,
- 10:18instead of having, for example, two
- 10:21chromosome 18s, the pregnancy having
- 10:24three chromosomes 18 is a risk
- 10:26condition, it increases the probability
- 10:29compared to other age groups, but it
- 10:32does not mean that this has to happen.
- 10:37The same goes for advanced paternal age
- 10:39at birth. It can also explain the
- 10:43emergence of pathogenic variants, new
- 10:46mutations precisely due to this
- 10:49mutation during spermatogenesis and the
- 10:52increase in proliferation cycles as it
- 10:55increases. the age of the male parent.
- 11:03Consanguinity, that is, couples who
- 11:05have parental relationships with each
- 11:07other, who are cousins, siblings, uncle
- 11:10and niece, etc., will be a risk factor
- 11:13for some entities that we will see that
- 11:15we classify as autosomal recessive and
- 11:18for other entities that we classify as
- 11:20multifactorial. Also, when a family
- 11:25tells us that there have been
- 11:27spontaneous and recurrent pregnancy
- 11:29losses, we begin to think that there
- 11:32may be a contribution of entities that
- 11:34are balanced, reciprocal translocations
- 11:37that are unbalanced in the product of
- 11:39the pregnancy, and also to know if the
- 11:42affected people have what chromosomal
- 11:44sex; that is, what sex chromosomes do
- 11:47they have, whether XX or xi, precisely
- 11:52to be able to distinguish some entities
- 11:54such as those linked to the chromosome.
- 11:58In other words, we do not ask just to
- 12:00ask, we ask because there is an
- 12:02objective of the right to health
- 12:06influencing. All this information that
- 12:11we ask, for example, how many newborns
- 12:14or gestational losses did the family
- 12:16have? Well, if there are people with
- 12:22cognitive disabilities, if there was
- 12:24someone in the family who was unable to
- 12:27conceive, etc., we have to write them
- 12:30down and systematize and standardize
- 12:33all the data that we are collecting.
- 12:38And there has been a nomenclature for
- 12:41family trees that has been standardized
- 12:44and international for many years.
- 12:49Mainly Benet's group is the one that
- 12:52has been systematizing the symbology
- 12:55year after year since the 90s and
- 12:59publishing and updating it for all
- 13:02countries. It means that a person, a
- 13:06medical professional writes down a
- 13:09genealogy in China, the United States,
- 13:12Russia, South Africa, Argentina, France
- 13:15, in the same way. And since it is in
- 13:19English here, right?,it says that
- 13:21precisely this preparation of family
- 13:26trees is a standard skill, that is,
- 13:29basic, standardized and systematized
- 13:32for all health professionals. In other
- 13:36words, all health professionals, nurses
- 13:39, kinesiologists, obstetricians,
- 13:41doctors, doctors of any branch, must
- 13:44know this practice. only geneticists.
- 13:50Let us examine then how we graph
- 13:52relevant family history and the manner
- 13:54in which we relate those details by
- 13:57using genealogical trees. This is the
- 14:02text we use, right? Where the
- 14:05nomenclature is in this article. They
- 14:09will surely have it uploaded on campus
- 14:11as well. Uh, unfortunately it is in
- 14:14English. English is the language in
- 14:17which Benete writes, let's say, and you
- 14:21will see that we can translate it and
- 14:24let's say that it is not that difficult
- 14:27to understand, let's say, the meaning
- 14:30of the words even though they are in
- 14:33English. For example, when we have to
- 14:38graph each individual, those whose
- 14:41gender is male, we use a figure that is
- 14:43a square. Those whose gender is female,
- 14:49we use a figure that is a circle and
- 14:52whose gender is not specified. We put
- 14:56for example or rhombus. You hear that I
- 15:00am using the word gender and I am not
- 15:02using the word sex. It means that here
- 15:06we are going to represent in these
- 15:09figures the gender by which the person
- 15:11perceives themselves. Here you are
- 15:15seeing that there are words and numbers
- 15:19outside the figure and for example this
- 15:22is B for born. And for this in this
- 15:25annotation, they are putting the year
- 15:27of birth, right? To count the age. One
- 15:31of the ways is to put, for example, the
- 15:33year of birth or to put directly 30
- 15:35years. Y is for year, which is year in
- 15:40English or 4 months. This mo is for
- 15:43month in English, which means months.
- 15:46It means that outside the figure the
- 15:49number that I am putting indicates the
- 15:51age of that person. Then, if any of
- 15:55these people are affected, I am going
- 15:58to color, I am going to shade, right?
- 16:01That figure. And if it has more than
- 16:03two conditions, or a condition that has
- 16:06many different signs, well, I am going
- 16:08to put a reference by partitioning the
- 16:11figure and saying: well, this symbol of
- 16:13horizontal stripes is going to mean
- 16:16this; the whole shaded one is going to
- 16:18mean the other; the vertical or
- 16:20diagonal stripes, another, to be able
- 16:23to see graphically how those signs or
- 16:25those conditions are distributed in the
- 16:28different individuals that make up that
- 16:30tree. family tree or that family. When
- 16:35we put numbers inside the figure, this
- 16:37is outside, it's the age, inside, it's
- 16:39the number of people who have that
- 16:41gender. So, what I'm saying here is
- 16:44that there are five males or five
- 16:46people of the masculine gender. Yes,
- 16:49sometimes we have families with many
- 16:51individuals, I don't know, they tell
- 16:53you there are eight siblings, none of
- 16:55whom have any history and they tell you
- 16:57there are five males, three females. So
- 16:59, in order to avoid drawing five little
- 17:01squares, you make a little square, a
- 17:03five inside and abbreviate it. If
- 17:06someone has passed away, I can see the
- 17:09figure and I can put either the age of
- 17:11death or the date, the year in which
- 17:14they passed away. Here there is a very
- 17:19subtle difference between what we call
- 17:21the consultant and the proband. Yes,
- 17:24the person who consults, that is, the
- 17:26one who comes to the consultation, we
- 17:29are going to point them out with an
- 17:31arrow. This is the person who came to
- 17:34consult us, although we are going to
- 17:35graph their entire family. Now, the
- 17:39proband is sometimes the same person
- 17:41who consulted, right? And so they may
- 17:44be affected and, uh, in addition to
- 17:47that, they are going to be the one I am
- 17:49going to start the study with. That is,
- 17:53when a person who This person is
- 17:55neither the affected individual nor the
- 17:57one I will test genetically; I will
- 17:59list them as a consultant, I'll
- 18:01indicate that, and nothing more. But if
- 18:05that person, in addition to being
- 18:08consulted, is affected and is the one
- 18:11who has the greatest possibility of
- 18:13perhaps finding the pathogenic variant
- 18:16for which I am evaluating, that person
- 18:19becomes the proband. The proband
- 18:23necessarily has to be the consultant,
- 18:25right? It could be that the grandmother
- 18:28came to consult and the proband
- 18:30initially is the grandchild, for
- 18:31example. Then we have fetal losses that
- 18:37we list if we know the sex. In this
- 18:42case, we list the figures and cross out
- 18:45that figure and we list how many weeks
- 18:47the loss was. If it was 28 weeks, 30
- 18:51weeks, 34 weeks. Note that we also add
- 18:56the symbol to distinguish it from this
- 18:59one, right?, which are deaths in
- 19:02postnatal individuals. We put SB, which
- 19:05means stillbirth or dead fetus. Now, if
- 19:11they were abortions, which are
- 19:14abortions before week 24, we are going
- 19:19to use these. triangles. If it was a
- 19:23spontaneous abortion and it was not
- 19:25affected, a white triangle. If it was
- 19:30an abortion, it was a decision to
- 19:32terminate the pregnancy and it is not
- 19:35affected, well, the symbol is unshaded
- 19:38but crossed out. If it was an ectopic
- 19:43pregnancy, that is, a gestation that,
- 19:46for example, instead of implanting in
- 19:48the uterus it was in a fallopian tube,
- 19:51it is and is not affected, it has this
- 19:53same symbolism, but below we add that T
- 19:56that comes from ectopic, that is, out
- 19:58of place, out of the correct place. Now
- 20:03, in these cases in which it is
- 20:05affected, either by a spontaneous
- 20:07arrest, a spontaneous abortion of the
- 20:10pregnancy, or by an induced termination
- 20:13or a decision to terminate the
- 20:15pregnancy, then the difference as it is
- 20:18affected, we shade them both, but the
- 20:21one that was an elective termination is
- 20:24the one we cross out, the fibula. In
- 20:28the case of how we represent the
- 20:30pregnancy, if we know, for example, the
- 20:33chromosomal sex, we can put the figure
- 20:36square, circle or rectangle. And inside
- 20:40the figure Let's put the letter P. Note
- 20:43that the P outside the figure is "
- 20:45proband", which is the person in whom
- 20:48it is affected and I'm going to start
- 20:51doing the studies. But if the letter P
- 20:55is inside the figure, it's not telling
- 20:58me about "proband", but rather about
- 21:01pregnancy. And the P goes to gestation,
- 21:06not to the pregnant woman. I don't put
- 21:09a P for the pregnant woman, I put P for
- 21:12gestation. There are some more symbols.
- 21:16Let's check some things that seem
- 21:19important to me. Rest assured that
- 21:22we're not going to see the 100
- 21:24different symbols that there are, but
- 21:26we're going to observe those that are
- 21:28interesting. One of the things that in
- 21:32order to have a representative and
- 21:35informative family tree, we need it to
- 21:39be able to contain information from at
- 21:42least three generations. For example,
- 21:46grandparents, parents, children with
- 21:49their respective uncles and nephews.
- 21:54Another important thing is the quality
- 21:57of the data to then do what we've been
- 21:59insisting on since part A of this
- 22:02seminar, the correlations, genotype,
- 22:05phenotype. For example, look at this
- 22:09symbol. This symbol shows a woman with
- 22:12an asterisk. It tells me that the
- 22:16asterisk tells me that the
- 22:17documentation was evaluated by our team
- 22:20or that if we didn't do it, for example
- 22:23, the study, we did a review and the
- 22:26information was verified. It is not the
- 22:32same for this woman to tell me, "I have
- 22:35never had any heart problems," than for
- 22:38her to come and show me she has a
- 22:40negative echocardiogram; that is to say
- 22:43, the echocardiogram rules out, for
- 22:46example, malformations of the heart
- 22:48chambers. So, obviously, the quality of
- 22:51the data is different for the woman who
- 22:52tells me, "No, nothing has ever
- 22:52happened to my heart." So, obviously,
- 22:54the level of quality of the data for
- 22:55the woman who tells me, "No, nothing
- 22:55has ever happened to my heart. Oh, I
- 22:56have an echocardiogram." Well, when I
- 23:00have to do these genotype-phenotype
- 23:02correlations, looking for variants that
- 23:04are truly significant for the pathology
- 23:06that this person is suffering from,
- 23:12then, if I have this degree of no, look
- 23:14, they have an echocardiogram that is
- 23:17indicating that they do not have a
- 23:19heart malformation, those variants that
- 23:21are associated with heart malformations
- 23:24, for example, I could make the
- 23:26decision, if it suits me...No, a lot of
- 23:29things, to rule them out and look at
- 23:31other variants. Another piece of
- 23:36symbology that I find important is that
- 23:38of the carrier, or bearer in English.
- 23:43In other words, a person who is a
- 23:45carrier means that they have the
- 23:47variant that I am looking for. This
- 23:50could be because I am going to do a
- 23:53test and it told me that they have the
- 23:55variant at the genotype level or
- 23:58because the consequences that I am
- 24:00seeing from the family tree show me as
- 24:03a result of previous generations and
- 24:05the generations that follow that they
- 24:08are an obligate carrier. So, what do I
- 24:11do with the figure? If the patient is
- 24:14not affected and is a carrier of this
- 24:16variant that we are analyzing, I will
- 24:18put a dot in the center. Note again
- 24:22that the P, I will name this again,
- 24:25when it is outside it symbolizes the
- 24:29proband. When it is inside the figure
- 24:34it symbolizes pregnancy. And the
- 24:37carrier does not go with any P, it goes
- 24:40directly with a dot in the center of
- 24:42the figure. Yes? I emphasize this
- 24:46because many times there are these
- 24:48errors in the interpretation of family
- 24:50trees. I continue to look at the
- 24:53quality of the data and I look at this
- 24:56case. Look, we are going to combine
- 24:58both things, the carriers with the
- 25:00evaluation documentation. Look what I
- 25:04have here. I have a female person or
- 25:09affected female gender. That is why her
- 25:13figure is shaded and has an asterisk,
- 25:16that is, a study was done on her and it
- 25:19is reliable, it was verified. That
- 25:22study gave her a positive result,
- 25:24instead of negative as it did here. And
- 25:27what was found? It was found that she
- 25:30has a variant; In this case, it is
- 25:32symbolized from the protein's point of
- 25:35view, that is, a deletion involving the
- 25:38loss of phenylalanine 508 and a second
- 25:40uncertain variant. In other words,
- 25:44since the pathology requires two
- 25:46variants in order to express itself,
- 25:49this one that we are going to see later
- 25:51, which is cystic fibrosis, one half
- 25:54positive and the other uncertain or not
- 25:57yet identified by the characteristics
- 26:02of the family tree and the genotype. It
- 26:04gave me that the male parent is
- 26:07positive for one of the two variants.
- 26:10The other is white type, that is, he
- 26:12has this one and the other in this case
- 26:14is w type, right? He is a carrier. And
- 26:18the mother, since I need two variants
- 26:21for the girl to have the condition, is
- 26:23an obligate cutter. And notice that she
- 26:27has a wild type variant that is graphic
- 26:30here and the uncertain variant that we
- 26:32are looking for. So here I have the
- 26:36defined genotype of these two
- 26:39individuals with an unknown variant,
- 26:42one of which comes from the mother and
- 26:45I also use the carrier sign. And here
- 26:49again I am saying that there is a male
- 26:53fetus that is affected by the P. Surely
- 26:56this condition, as it is trisomy 18,
- 26:59must have several malformations that I
- 27:02can see by ultrasound and in addition
- 27:05to that I did a karyotype study that
- 27:08came back positive. CBS is in chorionic
- 27:13villus sampling, where he has an extra
- 27:16chromosome which is 18. Instead of
- 27:19having 46 chromosomes he has 47. The
- 27:22chromosomal sex is male and the extra
- 27:26one is 18. Let's continue to see what
- 27:34you can come up with here or what
- 27:37information we can begin to interpret
- 27:39from this genealogy. We said at least
- 27:42three generations. We see that there
- 27:45are three generations. The way to place
- 27:49the generations is from the oldest to
- 27:51the newest. Let's move on to the Roman
- 27:55numerals: first generation, second and
- 27:58third. We are seeing that this P
- 28:01pointing at me is pointing at a female
- 28:07person, of feminine gender, named Ana,
- 28:10who is 15 years old and has some sign
- 28:14or condition because she is painted,
- 28:17there is no reference to which one, but
- 28:21she is painted. What else can we say
- 28:24about Ana? That Ana has a sister who is
- 28:27the daughter of the same father and
- 28:29mother. Here we see Ana's parents. You
- 28:33see how the couple joins with a
- 28:35horizontal line and the descendants
- 28:38emerge after the vertical line.
- 28:42Regarding Ana's father, what we see is
- 28:45that he has two brothers, that is, Ana
- 28:48has an aunt and a paternal uncle. On
- 28:53Ana's mother's side there are also two
- 28:55male brothers and a female sister. It
- 28:59means that Ana has one, two, three
- 29:02maternal uncles, two male and one
- 29:06female. What else? We have Ana's
- 29:09grandparents, Jorge and her paternal
- 29:11grandmother. And here the maternal
- 29:14grandparents. We see that Jorge has the
- 29:17symbol that he is deceased. At what age
- 29:21did he die? At 77 years old. What did
- 29:25he die of? Here is an acronym which is
- 29:28I am, acute myocardial infarction, a
- 29:31heart attack in the heart muscle. See
- 29:37how in this first family tree we can
- 29:39identify an affected person who is the
- 29:42proband, their age, who they are and
- 29:44the relationships they have with other
- 29:46family members. In other words, who is
- 29:49who? Who is the grandfather? Who is the
- 29:51uncle? Who is the father? Who is the
- 29:53mother? Now let's look at this tree for
- 29:58Ana, how the information obtained was
- 30:01increased. That symbol for Ana that was
- 30:05colored in red was a syndrome phenotype
- 30:12, in other words, she was born with a
- 30:15condition that at a clinical phenotypic
- 30:18level is defined as a syndrome. If she
- 30:22had some confirmatory and reviewed
- 30:24study, it has an asterisk and the study
- 30:27came back positive. In this case, it is
- 30:32a karyotype in which it was found that
- 30:35she has an extra chromosome instead of
- 30:3946 or 47, and the extra chromosome is
- 30:4221, that is, she has trisomy 21.
- 30:44Trisomy 21 is associated with Dada
- 30:47syndrome. Let's keep looking. Another
- 30:52detail is that it appears the mother is
- 30:55named Beatriz and is currently
- 30:57fifty-five years old. If we subtract
- 31:0255-15, it means that Beatriz had Ana at
- 31:0640 years old. Here we have something
- 31:10that we can call a risk factor or
- 31:12condition. Beatriz's advanced maternal
- 31:16age was 40 years old when Ana was born.
- 31:22Let's look at other symbols, so we can
- 31:25see how we work with family trees. Some
- 31:29of us already know the P inside the
- 31:31figure is pregnancy, that is, the sign
- 31:34of pregnancy. In this case, we still
- 31:36don't know the sex or gender of the
- 31:39fetus, nothing, we can't identify it.
- 31:41We put a figure of indeterminacy which
- 31:45is the diamond. This couple whose male
- 31:51person is the consultant. Notice that
- 31:55it has an arrow and nothing else. It is
- 31:57neither affected nor does it have PE
- 31:58testing. She had a previous child with
- 32:02her reproductive partner and this
- 32:04pregnancy that is in progress. However,
- 32:08this woman has already had a previous
- 32:10male child with another partner. You
- 32:13see that he is not involved in this
- 32:15bond of brotherhood, he is outside. And
- 32:18this, uh, male parent, this part of the
- 32:21couple, also had a previous daughter
- 32:24with another woman from whom he is now
- 32:27separated, that is why there is that
- 32:29crossed out line in the bond. And this
- 32:33woman, on the other hand, had an
- 32:35unaffected miscarriage with another
- 32:37partner. Yes. Notice how here we have a
- 32:42lot of symbols that we are beginning to
- 32:45recognize. We also have some symbols
- 32:51that can be useful, for example, how we
- 32:53mark consanguinity. If the two parents,
- 32:57for example, are cousins, siblings to
- 33:00each other, we make a double line in
- 33:02the pair. If the offspring is related
- 33:07to twinning processes and the twinning
- 33:10is monozygotic, it has this symbolism,
- 33:13that is, they both come from the same
- 33:15egg cell, then they will have the same
- 33:18genetic information. If it is disygotic
- 33:23, this twinning is the product of two
- 33:26different egg cells, so they will not
- 33:29have the same genetic information, but
- 33:31will share the uterine environment, but
- 33:34will present the same variability as
- 33:37any other group of siblings. And when
- 33:43we do not know if it is monozygotic or
- 33:45disygotic, we put this question mark.
- 33:48What happens in cases of fertilization
- 33:51and assisted reproduction techniques?
- 33:54Many times there may be a couple where
- 33:57there is a gamete donor. Here what we
- 34:01are seeing is that this couple has a
- 34:04pregnancy in progress. We see the P
- 34:07that we do not yet know the sex of the
- 34:10fetus. And in this case the woman
- 34:15provided the oocytes, but the sperm
- 34:19were given by a donor. So, for the
- 34:25sperm donor, we placed the letter D,
- 34:28standing for donor, within the
- 34:30symbology we are using. It is also
- 34:35important to know whether a couple does
- 34:38not have children, whether it has to do
- 34:41with a personal decision or an already
- 34:44defined case of infertility. So, based
- 34:48on that, note that when there are no
- 34:50offspring, depending on whether it is a
- 34:52defined infertility or not having
- 34:54children due to a personal decision,
- 34:59the lines are different. Personal
- 35:03decisions can also tell us if there was
- 35:07a therapeutic technique involved, such
- 35:10as a basectomy in this case or tubal
- 35:14ligation, right? Tubal ligation, as it
- 35:18is more colloquially called, or if the
- 35:21infertility refers to a problem of
- 35:24aspermia, for example. In other words,
- 35:27here we are indicating the reasons and
- 35:29we know them, right? That is, the lack
- 35:31of sperm or entities that have to do
- 35:34with alterations in the endometrium,
- 35:40such as endometriosis or an abnormal
- 35:42and out-of-place endometrium. Let me
- 35:50tell you something else that can happen
- 35:52with these family trees and their
- 35:54internationally standardized symbology.
- 35:58There are times when we publish a case,
- 36:01a family, because we are analyzing, for
- 36:04example, a very important variant in
- 36:06this case of a gene specifically
- 36:09associated with amyotrophic lateral
- 36:11sclerosis. This is taken, as you can
- 36:15see, from a scientific article
- 36:17published in Nature. And this variant,
- 36:21notice that all the ones that were
- 36:23studied in the family or this family in
- 36:26its composition that has four
- 36:29generations, right? Generations 1, 2, 3
- 36:32and 4, instead of indicating their
- 36:35gender, each individual was given a
- 36:39diamond. Why do you ask me that they
- 36:42don't know the gender of each
- 36:43individual? Yes. But the aim was to
- 36:46preserve precisely that gender
- 36:49information so that no one could
- 36:52identify which family this genotypic
- 36:56segregation belongs to, where W stands
- 36:59for the allele, variant W type and M
- 37:03the different variant, that is, the one
- 37:07that has the substitution mutation. C
- 37:10for G in nucleotide 71. So, in this way
- 37:16it is a way of being able to make a
- 37:19publication, but on the other hand also
- 37:22respecting the confidentiality of
- 37:25personal or family data. Something else
- 37:31regarding symbolism and people's gender
- 37:34. Well, many times the sex assigned at
- 37:40birth coincides with people's gender
- 37:42choice, but sometimes it doesn't. So,
- 37:46how can we graph that? Precisely also
- 37:50taking into account the different
- 37:53health conditions that can arise from
- 37:58the different genders and different
- 38:01sexes. So, this graph, this
- 38:05double-entry chart, which is where the
- 38:07symbolism is, which is also from
- 38:10Benet's group, as you can see here, in
- 38:122021 that was published in 2022,
- 38:14precisely reviewing these issues of how
- 38:17to symbolize gender and sex. So, in the
- 38:23same person, this standardized
- 38:26consensus was reached. For example,
- 38:30follow me slowly. Here in these columns
- 38:34is the sex at birth, which can be a sex
- 38:37that has been assigned by the external
- 38:40genitalia. Many times the sex at birth,
- 38:44the baby is born, you look at the
- 38:46internal and external genitalia, sorry.
- 38:50That is, if they have a vulva and/or if
- 38:52they have a scrotum and penis and from
- 38:55there it is called female vulva vagina,
- 38:57male penis scrotum, right? That may be
- 39:01the simplest and most popular way of
- 39:04assigning sex at birth, but obviously
- 39:06it is a sex which is defined
- 39:08exclusively by the appearance of the
- 39:11external genitalia. So, notice that at
- 39:15birth someone may have assigned with
- 39:18that category of external genitalia
- 39:21those who are male, those who are
- 39:24female or those who had indeterminate
- 39:27genitalia were not assigned them. Then
- 39:33we will see what happens with gender.
- 39:38These will be in the rows, right? That
- 39:42is to say, someone can self-perceive as
- 39:46male, female or non-binary. So, someone
- 39:51who was assigned male at birth because
- 39:54of their external genitalia and their
- 39:57gender by self-perception and
- 40:00identification is male, we are going to
- 40:03put a figure, as we have been putting
- 40:06in this case, a square and only if they
- 40:10are not affected or anything, their age
- 40:13at this time, 56 years old. If a person
- 40:18was assigned male at birth based on
- 40:21their external genitalia, but today
- 40:24they perceive themselves as feminine,
- 40:27we are going to graph them as feminine,
- 40:31a circle, and we are going to put their
- 40:35age, but we are going to add this
- 40:38acronym, which means they were assigned
- 40:41male at birth. Precisely so that we can
- 40:47understand that although they perceive
- 40:50themselves as feminine and have that
- 40:53identification as a person, they may
- 40:56still have male internal sexual organs
- 40:59that the health system should monitor,
- 41:02such as at age 56 and beyond. What
- 41:05happens to the prostate? What happens
- 41:13to the person who was assigned male at
- 41:15birth based on their genitalia, but
- 41:17today they identify as non-binary. We
- 41:21are also going to put amab, that is,
- 41:24assigned male at birth, their age, but
- 41:27since they identify as non-binary, we
- 41:30are going to put a diamond on their, uh
- 41:33, as a geometric symbol of their person
- 41:36. Similar, but let's say with a
- 41:42definition of assigned female at birth.
- 41:45It will happen in these cases. This
- 41:50person was assigned female at birth
- 41:52based on their external genitalia, but
- 41:54today they perceive themselves as
- 41:57masculine. I draw a square, which is
- 42:00their gender identification, and I add
- 42:02the information that they were assigned
- 42:05female. This person was assigned female
- 42:07at birth and self-identifies and
- 42:09perceives themselves as female. Nothing
- 42:12, I just draw a circle and it works. I
- 42:15don't have to add any legend. And this
- 42:20person was assigned female at birth,
- 42:23but today they identify with a
- 42:25non-binary gender. So we always draw a
- 42:29diamond, as you can see, whether it's a
- 42:32square, circle, or diamond has to do
- 42:35with the person's self-perception of
- 42:37gender. What happened at the level of
- 42:41the external genitalia at birth? We're
- 42:43going to add it with these legends here
- 42:46. This person was unassigned, that is,
- 42:50their external genitalia did not allow
- 42:53us to assign a sex at birth. This
- 42:55happens to all of them. So, all of them
- 42:59are going to have this acronym of not
- 43:02assigned at birth, but today they
- 43:04perceive themselves as male, so I draw
- 43:07the square symbol for male. They
- 43:11perceive themselves as female, I draw a
- 43:13circle that has to do with the female
- 43:15gender; or non-binary, self-perceives,
- 43:18and then their gender will be
- 43:19represented by the diamond. Some more
- 43:25information. As you can see, there are
- 43:29a lot of issues that we can ask, but
- 43:31let's talk about some of these
- 43:33reproductive situations. In this case,
- 43:38there is a transgender male, right?
- 43:43Note that he was assigned female at
- 43:46birth. Yes, but he self-perceives as
- 43:50male based on his gender. He is a trans
- 43:54man who has his partner and so what
- 44:00they both did was surrogate, that is,
- 44:03use their gametes. He was able to give
- 44:09his sperm gametes for that egg cell and
- 44:12this person was able to give her oocyte
- 44:16gametes, to be able to generate the
- 44:19product of fertilization, the egg cell,
- 44:23but they decided to surrogate the
- 44:26uterus in another person. Right? So
- 44:30this is the person who in this case has
- 44:36the gestation in her uterus. And here
- 44:42there are other cases where in addition
- 44:44to surrogacy, there is also egg
- 44:49donation, not just surrogacy, or there
- 44:53is double donation, right? Double egg
- 44:58donation. What else can I see as
- 45:05important when analyzing the genealogy?
- 45:09How are the clinical signs or
- 45:11conditions of affectation distributed?
- 45:15Who are those affected? How are they
- 45:18distributed? So, look at this first
- 45:21example. Generation one, there is one
- 45:24affected person. Generation two, there
- 45:25are two affected people. Generation
- 45:27three, there are affected people. There
- 45:29are affected people in all generations
- 45:31and they all come from the same branch.
- 45:34The branch, in this case, for this
- 45:36individual is the paternal branch, his
- 45:38father, his paternal grandfather, his
- 45:40paternal aunt. We are going to call
- 45:45this type of distribution a vertical
- 45:47pattern, where in all generations and
- 45:50mostly on the same branch there are
- 45:52affected people. This will give us
- 45:57clues later when we look at autosomal
- 46:00dominant entities, autosomal recessive
- 46:02X-linked entities. We are going to see
- 46:06that in each of them there is a special
- 46:08distribution pattern. For example, the
- 46:12vertical pattern can be one of the
- 46:15patterns that we are going to observe
- 46:17in autosomal dominant entities, even
- 46:20more so when there is a male-to-male
- 46:23transmission of a certain genotypic
- 46:25variant, that is, from one generation
- 46:28immediately to the next, a father to a
- 46:30male child. With this vertical pattern,
- 46:35it is very likely that the entity could
- 46:37have an autosomal dominant type of
- 46:40inheritance. I am going to tell you
- 46:42something that you will see in future
- 46:43classes. In a horizontal pattern, what
- 46:46does it mean? I see that the affected
- 46:48people, look, unlike the previous one,
- 46:51are all in the same generation. Here it
- 46:53is 1, 2, 3. In generation three. And
- 46:56they also all belong to the same
- 46:59sibling group. And here I have carriers
- 47:02. Okay. This is a horizontal pattern
- 47:07tree that one could very frequently
- 47:09associate with autosomal entities and
- 47:11sometimes there is no specific pattern.
- 47:15I see only one affected person and no
- 47:18others at all. Well, let's look at this
- 47:24tree. Let's start thinking about this
- 47:27tree together. What are we seeing? And
- 47:35then we see that there are three
- 47:37generations, that there are positive
- 47:39studies with proven genotype. We see
- 47:43affected individuals, do you remember?
- 47:45The affected individuals are shaded.
- 47:47What pattern do these affected
- 47:49individuals have? And we see it
- 47:51vertically, generation 1, 2, 3. We see
- 47:56the genotypes and we see that this
- 47:59affected individual has a heterozygous
- 48:01white type genotype, a deletion that,
- 48:04let's call it the quality in this case,
- 48:07that we know is pathogenic. While this
- 48:12other individual who has already passed
- 48:15away also has a genotype study and in
- 48:17this case it gave him wild type while
- 48:19type, right? In other words, he is
- 48:22homogous for the white type variant.
- 48:26Here we see the proband, right? The P
- 48:29pointing out is also an affected person
- 48:32and has the same genotype as his father
- 48:35. White type of lesion. His brother
- 48:39also. White type of lesion and his
- 48:41daughter also type of lesion. But what
- 48:45else do we observe in this second
- 48:47generation? Here there is another
- 48:52individual who is not shaded, he does
- 48:54not seem to be affected, but the
- 48:57symbology is healthy and he has the
- 48:59same genotype of the lesion and his
- 49:02children, who are all affected, we have
- 49:05not yet studied them from the genotypic
- 49:08point of view, but we see that his
- 49:10partner has both alleles with wide
- 49:13homoygosity. What is it that draws our
- 49:18attention about this second generation?
- 49:22What does it come from? It is the son
- 49:26of this affected person, it is the
- 49:28brother of these affected people, whose
- 49:30children are affected and who also
- 49:32share the genotype of the other
- 49:34affected people for that gene. This is
- 49:38a case in which one says, "Oh, on the
- 49:41one hand it seems that there is a
- 49:44generational gap. No, I mean, this
- 49:47generation is affected, this one is
- 49:49affected, but he, although his siblings
- 49:51are, he is not affected. But from what
- 49:56this family tree is showing me, it is
- 49:59clearly a case of incomplete penetrance
- 50:03. That is to say, I have the genotype,
- 50:07but in 100%of the cases that have this
- 50:10lesion variant, it is not showing me
- 50:13affected. Possibly there must be other
- 50:18effect-modifying genes that we did not
- 50:20take into account in this genotyping,
- 50:23which may be interacting with this
- 50:25lesion variant and not favoring its
- 50:28expression. But we will see that later.
- 50:33For now, stick with this. This is a
- 50:36case of incomplete penetrance. He has
- 50:39the genotype, but he is not affected.
- 50:44Let's look at this other tree. Each
- 50:48time we are adding more information so
- 50:52that you can work on it, get closer to
- 50:58interpreting the family trees. The
- 51:02proband is Diego, he has 15 years old,
- 51:04he is in the third generation of this
- 51:06family that I was questioning and he
- 51:08has, as we see here in the reference,
- 51:11mitral insufficiency. His father is
- 51:15Esteban, 45 years old. He also has
- 51:18mitral insufficiency, but he has also
- 51:21had dissection of the aorta, he has
- 51:23also had dilation, that is, both things
- 51:25began with dilation and ended with
- 51:27dissection of the aorta and he has also
- 51:30had dislocation of the lens, that is,
- 51:32the mitral valve, the aorta and the
- 51:34lens are all altered and seriously
- 51:36affected. Silvia is Diego's mother, she
- 51:41is 40 years old, she went out twice
- 51:43here, 40, uh, and she is not affected.
- 51:47And Diego's siblings, apparently they
- 51:49are not affected. Silvia's siblings
- 51:51aren't either, and Silvia's parents
- 51:53aren't either. Let's continue looking
- 51:57at the paternal side and we see that
- 51:59Esteban has siblings, yes, he has
- 52:02sisters who are dysygotic twins, what
- 52:04people call fraternal twins. Both of
- 52:09whom had mitral insufficiency in red
- 52:12and dilation of the aorta. They did not
- 52:15reach adulthood. dissection, right?, of
- 52:17the horta, the most serious part, but
- 52:20yes, they already have it dilated; that
- 52:22is to say, we have to take care of
- 52:25these twins because they can end up
- 52:27later in a dissection of the horta and
- 52:30one of them has the P, the P inside a
- 52:32diamond shape. What was that? Pregnancy
- 52:36. Pregnancy. Yes. The P outside testing
- 52:39. Look, she is the pregnant one, but I
- 52:42don't put the P to the pregnant one, I
- 52:44put the P to the product of the
- 52:46gestation, to the pregnancy. Yes. The
- 52:51other brother, mitral insufficiency and
- 52:54a subluxation of the lens. It's not
- 52:56fully dislocated; it is subluxated.
- 52:59Esteban has it worse, his lens is
- 53:01directly dislocated. This one has it
- 53:03subluxated and he has a son who has
- 53:06insufficiency. and it is very serious,
- 53:08he has dissection of the horta at such
- 53:10a young age. He does not, but his son
- 53:12does. And they have like dad Esteban,
- 53:17his father's name is Raúl, he passed
- 53:19away at the age of 69. Endocarditis, it
- 53:22means a bacterial infection probably of
- 53:25this mistral valve that was
- 53:27insufficient. He also did the
- 53:29dissection of the horta, the
- 53:31dislocation of the lens. Raúl ended up
- 53:34badly with stendocarditis and died.
- 53:37What do we have here? Well, do you
- 53:40remember that in part A of this seminar
- 53:42we had talked, for example, about an
- 53:45entity called Marfan, which could have
- 53:47abortion alterations, alterations in
- 53:49the spine that in this case, in this
- 53:51family, no one has, the green one—,
- 53:54which could have alterations in the
- 53:56lens, in the mitral valve? Well, again,
- 53:59this is a case of this disease called
- 54:01Marfan syndrome and we had said that
- 54:03there is the same gene, the gene that
- 54:06codes for fibrillin. Its variant could
- 54:09be, do you remember? Pleiotropic, that
- 54:12is, it affects different organs that
- 54:14are not related to each other, the
- 54:16spine, the lens, the horta, the mitral
- 54:18valve. The same pathogenic variant has
- 54:23effects on several different organs.
- 54:26And on the other hand, we are also
- 54:28seeing variable expressivity within the
- 54:31same family. That is, we have some that
- 54:36already have the dissection of the
- 54:38horta and others who have had only
- 54:41dilation or dilation and then
- 54:43dissection in a secondary way. Some
- 54:48have only the dislocation of the lens
- 54:51and others less so the subluxation of
- 54:53the lens. So here we are also seeing
- 54:57that this entity, in addition to being
- 55:00pleiotropic, several different organs
- 55:02affected, there is varying severity.
- 55:06There are some who have the dislocation
- 55:08of the lens, others the subluxation,
- 55:10which is somewhat milder. Some have the
- 55:12dilation of the horta and others
- 55:14already have the dissection of the
- 55:16horta which is more severe. So in this
- 55:20case we are seeing an example of
- 55:25pleiotropy and variant expressivity.
- 55:29And they ask us something else. In
- 55:31which generations do those affected
- 55:32predominate? And in the first, second
- 55:35and third of the same branch. It is
- 55:38clearly a vertical pattern. Is there a
- 55:41predominance of any sex, gender in
- 55:43those affected? There are not as many
- 55:45women as men. And in this case none are
- 55:48transgender or have a different
- 55:50assigned sex. In other words, in this
- 55:53case the word sex would also allude to
- 55:56or agree with the word gender. The
- 56:00signs belong to the same different
- 56:02entity. That will depend on what one
- 56:04knows about each entity. At first, if
- 56:07one does not know that this is Marfa,
- 56:09that it is caused by Marfan syndrome,
- 56:11one could think, oh, it is a family
- 56:13that has different diseases that are
- 56:15being distributed or chosen. This
- 56:18genealogy is informative. Of course, I
- 56:22see, I have a lot of signs and
- 56:24distribution of these signs that I find
- 56:26very informative. I would request some
- 56:31other study and it would be important
- 56:33perhaps to check the clinical part of
- 56:36Esteban's other children, ask this
- 56:38woman who is pregnant if she is having
- 56:41check-ups or not for this pregnancy,
- 56:43see if she wants to know or not if this
- 56:46pregnancy has the possibility of having
- 56:48the variant, etc. Let's look at another
- 56:54family tree. Let's see if you recognize
- 56:58symbols. Yes. Where are the affected
- 57:01ones? Well, we have them all
- 57:04concentrated in generation four. There
- 57:07are no affected ones in the others.
- 57:11What is the proband of this individual
- 57:13from generation four? What is it? What
- 57:17is the entity that affects them?
- 57:21Alvinism, that is, they have a decrease
- 57:23in pigmentation. cutaneous melanin. Yes
- 57:27, it could be, for example,
- 57:28oculocutaneous albinism, which lacks
- 57:30pigmentation in the iris, hair, and
- 57:33skin. What other symbols can we
- 57:36recognize here? The carrier sign, right
- 57:40? This is precisely an entity, this
- 57:43type of autosomal recessive albinism,
- 57:46for which the affected ones are
- 57:49expected to have both variants, that
- 57:51both are pathogenic, neither w type,
- 57:54and the carriers, one would expect
- 57:57heteropygosity, right? One w type
- 58:01variant and the other the pathogenic
- 58:03variant. Who is it? What other sign do
- 58:06we see here? The double line in the
- 58:10parents, in the parents of these
- 58:12affected people. Do you remember that
- 58:15it was a symbol of consanguinity? What
- 58:18consanguinity relationship do they have
- 58:20? And let's see, in the previous
- 58:24generation, this person is the mother
- 58:28of this individual and at the same time
- 58:32is her paternal aunt. And for this
- 58:38other carrier, he is her father and
- 58:41Also, the uncle, these two are brothers
- 58:45, and his paternal uncle. This means
- 58:49that this couple is made up of first
- 58:52cousins. One of these two from the
- 58:55first generation is probably going to
- 58:58be the carrier, but we don't know which
- 59:01one is the carrier just from a clinical
- 59:04perspective. In this case, we should
- 59:11genotype each of them to find out which
- 59:15one is the carrier. So they ask us, in
- 59:19which generation do those affected
- 59:21predominate? In the fourth. It's a
- 59:24horizontal type and sibling pattern.
- 59:28They all belong to the same entity. Yes
- 59:30. And besides, there are no different
- 59:32signs, but they're all painted the same
- 59:34, without reference. Is there a
- 59:37predominance of one sex? There aren't
- 59:40as many males as females. Is this
- 59:43genealogy informative? Yes, because I
- 59:46also have the risk factor of
- 59:47consanguinity that is giving me the
- 59:50idea that there are several obligate
- 59:52carriers. This other person could be an
- 59:57obligate carrier, it could be, but we
- 59:59don't know. They have a 50%chance of
- 1:00:03being a carrier, as we'll see later. On
- 1:00:07the other hand, this one, Since all of
- 1:00:09his children are affected, he is
- 1:00:11definitely a carrier of the pathogenic
- 1:00:13variant. This image, the cover of a
- 1:00:17book titled Alicunia, Portrait of a
- 1:00:20Continent, is one I recommend. Written
- 1:00:24by Argentine geneticist Eduardo
- 1:00:25Castilla and his son, it recounts their
- 1:00:27personal story in Aicuña, a town in La
- 1:00:29Rioja where albinos have long
- 1:00:31predominated. The book explores how
- 1:00:33this unique genetic history has
- 1:00:34persisted among the local inhabitants
- 1:00:36who stayed in the area for many years.
- 1:00:39You have to read the text, but it is
- 1:00:39quite interesting how there are
- 1:00:40processes of inheritance and care for
- 1:00:46the land, of not losing the land that
- 1:00:53they had inherited, which generates a
- 1:00:54kind of non-geographic isolation
- 1:00:54because although there are mountains,
- 1:00:55there is a socioeconomic isolation in
- 1:00:56which people prefer to stay rather than
- 1:00:57move to another town, and that
- 1:00:58generates a higher frequency of a
- 1:00:59variant that will lead to albinism. You
- 1:01:01have to read the text, but it is quite
- 1:01:04interesting how there are processes of
- 1:01:06inheritance and care for the land, of
- 1:01:09not losing the land that they had
- 1:01:11inherited, which generates it as a
- 1:01:13non-geographic isolation because
- 1:01:16although there are mountains, there is
- 1:01:18a socioeconomic isolation in which
- 1:01:20people prefer to stay rather than move
- 1:01:23to another town, and that generates a
- 1:01:27higher frequency of a variant that will
- 1:01:30lead to albinism. oculocutaneous. It is
- 1:01:34very interesting how it is related and
- 1:01:37the Apuña genealogy that has more than
- 1:01:3915 documented generations. Let's wrap
- 1:01:44it up. Why are genealogies important?
- 1:01:49Because I graphically represent
- 1:01:51biologically related individuals, I can
- 1:01:54represent their conditions or risk
- 1:01:57factors, I can represent their
- 1:01:59different clinical signs or directly a
- 1:02:02closed clinical entity such as albinism
- 1:02:04. In this tree I already closed the
- 1:02:09entity with albinism, but in these
- 1:02:11others we saw signs of an entity that I
- 1:02:13could have later closed as a clinical
- 1:02:15physician, a medical geneticist, such
- 1:02:17as Marfan. Obviously, it allows me to
- 1:02:23visualize specific inheritance patterns
- 1:02:25, to be able to suspect, as we had
- 1:02:28discussed before, if it is vertical, if
- 1:02:31it is horizontal, if it leans more
- 1:02:33towards an autosomal dominant entity,
- 1:02:36an autosomal recessive one. There are
- 1:02:41specific symbologies to indicate the
- 1:02:43quality of the data, if it has a
- 1:02:44positive study or not, if it has no
- 1:02:46study. Symbologies for different
- 1:02:49reproductive contexts to distinguish
- 1:02:52between gender, chronosomal sex and sex
- 1:02:54of external genitalia at birth. Very
- 1:02:58important. It is not advisable to
- 1:03:00invent symbols locally. In other words,
- 1:03:03Oh, I can't think of how to put this,
- 1:03:06I'll make up a symbol for my family
- 1:03:07trees. Not using internationally
- 1:03:11standardized genealogy not only allows
- 1:03:14us to communicate, no matter what
- 1:03:17country or language it is, but it also
- 1:03:20allows me to make comparisons between
- 1:03:23the results of different studies. I can
- 1:03:27compare. Finally, of what we're going
- 1:03:34to see today, what we also do after the
- 1:03:36anamnesis and the preparation, we're
- 1:03:39not going to do this whole thing, but
- 1:03:41up to here is the complete physical
- 1:03:43examination; that is, we evaluate each
- 1:03:45person in the family who has come to
- 1:03:47consult us systematically from feet to
- 1:03:50toe, from head to toe or from head to
- 1:03:52toe. We measure everything, even the
- 1:03:55head circumference, height, weight. The
- 1:03:58signs in the eyes, on the noses, on the
- 1:04:01hands, patterns of furrows on the hands
- 1:04:03, feet, we see if they have ossicles,
- 1:04:05we see if they have spots on the skin,
- 1:04:08we examine them and see how they
- 1:04:10breathe, we see how the heart sounds
- 1:04:12are. Well, a very thorough complete
- 1:04:15examination. So The important thing is
- 1:04:20that we have many signs that will help
- 1:04:22us, for example, to search for certain
- 1:04:25clinical conditions, especially when we
- 1:04:28don't suspect a disease, and also to
- 1:04:31look for variants. But imagine if each
- 1:04:35doctor writes down the signs or
- 1:04:38entities in the way they want, it would
- 1:04:41be very difficult to then be able to do
- 1:04:43these searches, to compare or
- 1:04:46standardize results, or to use
- 1:04:50bioinformatics programs. So, for many
- 1:04:55years now, there has been a
- 1:04:57standardized way with code to enter
- 1:04:59each phenotypic trait, which are these
- 1:05:02HP codes that come from HumanType
- 1:05:04Ontology, right? And within HumanType
- 1:05:09Ontology, there is also a tool called
- 1:05:11Phenomizer, that is, a way to perform
- 1:05:15phenotype searches where one enters
- 1:05:17these HP codes and looks for what
- 1:05:22different clinical diagnoses could
- 1:05:25correspond and what variants or genes
- 1:05:28and their variants could be associated
- 1:05:31to go looking for specific targeted
- 1:05:34genetic tests or to do the filters
- 1:05:37during bioinformatics panelizations in
- 1:05:40massive sequencing. So, look, For
- 1:05:45example, there are some signs that are
- 1:05:47very minimal. These are some little
- 1:05:50dimples here, I'm not sure if you see
- 1:05:52them; one dimple and another on the
- 1:05:54lower side level. There is an HP code
- 1:05:58that is this triple 0196 that here says
- 1:06:02precisely lower lip. Pit is a small
- 1:06:05hole. Yes. Small holes in the lower lip
- 1:06:08. And if I put in Phenomizer to look
- 1:06:11for entities that have this, it shows
- 1:06:14me three. There are other signs such as
- 1:06:18cognitive disability that can show me
- 1:06:21100 different entities. In other words,
- 1:06:24depending on which sign I put, the
- 1:06:26spectrum of disease that I am going to
- 1:06:28look for can be very restricted or very
- 1:06:31broad. And look, one of them is
- 1:06:34Vanderwood, Vanderwood syndrome. And
- 1:06:38when I look for it, it has a highly
- 1:06:40significant value and I even know which
- 1:06:43gene is associated with this entity to
- 1:06:45go look for the pathogenic variants.
- 1:06:49See how we are using the phenotype, a
- 1:06:52standardized phenotype in a code to do
- 1:06:56a search at the genotype level of a
- 1:06:59certain variant and make these
- 1:07:01correlations. genotype, phenotype and
- 1:07:04to be able to make a diagnosis in this
- 1:07:07case in this little patient. Well, we
- 1:07:11are going to continue in other seminars
- 1:07:13to go over the tour. Today we are
- 1:07:16staying here in this first part of the
- 1:07:19tour and I wanted to finish by sharing
- 1:07:22this phrase for all of you that is from
- 1:07:24Alba Einstein, it is not mine, which
- 1:07:27says:" We are all geniuses, but if you
- 1:07:29judge a fish by its ability to climb
- 1:07:32trees, it will live its whole life
- 1:07:34thinking that it is useless. "Thank you
- 1:07:39very much and remember that we have a
- 1:07:42space for the questions in the seminar
- 1:07:44discussion so that you can go and ask
- 1:07:47them. I hope that seminar 10, both
- 1:07:51parts A and B, have been useful to you.
- 1:07:54Thank you.
About this transcript
This page contains the full transcript of Seminario 10 PARTE B Introducción a la Genética Medica - María Paz Bidondo by Biología Molecular y Genética FMED - UBA, generated from the public captions YouTube serves with the video. The transcript has 8,905 words across 1,345 segments, with the original timestamps preserved so you can click any line to jump to that moment in the embedded player.
What you can do with it
Use the transcript to take notes, quote the speaker, build a study guide, generate a summary with ChatGPT or Claude via the YouTube Summary tool, or export it as a timed subtitle file with YouTube to SRT. You can also re-open it in the transcriber to choose a caption track available on the video.
Free YouTube transcript tool
YouTube2Text is a free YouTube transcript generator — no signup, no daily limit. Paste any YouTube link and get the full transcript instantly, with timestamps, click-to-jump, caption language selection, AI prompts for ChatGPT, Claude, and Gemini, and exports to TXT, SRT, VTT, or Markdown.